13D Filing: Biotechnology Value Fund LP and BioLineRX Ltd. (BLRX)

SCHEDULE A

Transactions in the Securities
of the Issuer During the Past Sixty Days

Class of Security

Securities Purchased / (Sold)

Price ($)

Date of Purchase / Sale

 

BIOTECHNOLOGY VALUE FUND,
L.P.

ADSs*	4,090,714	+	07/26/2017
Series A Warrant**	1,431,750	+	07/26/2017
Series B Warrant**	1,431,750	+	07/26/2017

 

BIOTECHNOLOGY VALUE FUND II, L.P.

ADSs*	2,551,544	+	07/26/2017
Series A Warrant**	893,040	+	07/26/2017
Series B Warrant**	893,040	+	07/26/2017

BIOTECHNOLOGY VALUE TRADING FUND
OS LP

ADSs*	708,020	+	07/26/2017
Series A Warrant**	247,807	+	07/26/2017
Series B Warrant**	247,807	+	07/26/2017

BVF PARTNERS L.P. (THROUGH THE
PARTNERS MANAGED ACCOUNTS)

ADSs*	1,145,297	+	07/26/2017
Series A Warrant**	400,854	+	07/26/2017
Series B Warrant**	400,854	+	07/26/2017

* Each ADS represents one Share.

** Each Warrant entitles to the Reporting Person to
purchase ADSs representing an equal number of Shares, at an exercise price of $2.00 for Series A Warrants and at an exercise
price of $4.00 for Series B Warrants.

⁺ Purchases made pursuant to the Subscription
Agreement.